Latest advances in targeted biologic therapy for myasthenia gravis: from complement inhibition to FcRn antagonism

LI Xue, SHI Jina, LIU Yanjun, LIU Wei

PDF(802 KB)
Welcome to Current Immunology, Today is
PDF(802 KB)
Current Immunology ›› 2026, Vol. 46 ›› Issue (4) : 555-560.

Latest advances in targeted biologic therapy for myasthenia gravis: from complement inhibition to FcRn antagonism

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2026, 46(4): 555-560

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(802 KB)

Accesses

Citation

Detail
Sections
Recommended
Contact
Add: 1 / f, library 1, no.280, south chongqing road, Shangha
Code: 200025
Tel: 021-53062055
E-mail: currentimmunol@126.com
visited
Total visitors:
Visitors of today:
Now online:
Copyright © 2022 Current Immunology

/

〈 〉